Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other financing activities: 2014-2020

  • Veracyte's Other financing activities fell 21.34% to $3.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $12.8 million, marking a year-over-year increase of 46.10%. This contributed to the annual value of $129,000 for FY2014, which is 98.16% down from last year.
  • As of Q3 2020, Veracyte's Other financing activities stood at $3.3 million, which was up 239.35% from $981,000 recorded in Q2 2020.
  • Veracyte's Other financing activities' 5-year high stood at $4.2 million during Q2 2019, with a 5-year trough of $148,000 in Q1 2016.
  • In the last 2 years, Veracyte's Other financing activities had a median value of $3.8 million in 2019 and averaged $3.2 million.
  • Data for Veracyte's Other financing activities shows a maximum YoY tumbled of 76.86% (in 2020) over the last 5 years.
  • Veracyte's Other financing activities (Quarterly) stood at $148,000 in 2016, then reached $4.2 million in 2019, then dropped by 21.34% to $3.3 million in 2020.
  • Its last three reported values are $3.3 million in Q3 2020, $981,000 for Q2 2020, and $4.2 million during Q3 2019.